dpp-4 inhibitors vs. glp-1 agonist Dipeptidyl peptidase-4 inhibitor Differences between GLP-1 receptor agonists

10.1001/jamanetworkopen.2024.6221

Other New Stuff: The Genetics of G-Agonists In a seminal study of the genomics of glucose regulation in nearly 500,000 people, specific coding variants of the GLP-1 receptor (GLP1R) were associated with potential GLP-1 drug response

For potentially vulnerable populations, 0.75 mg once weekly can be considered as a starting dose

Further research is needed to explore the full therapeutic potential and long-term safety of GLP-1RAs across a broader range of metabolic and neurodegenerative disorders

(2015b)

Ischemic Optic Neuropathy with Semaglutide: Global Observational Analysis of Sex- and Formulation-Specific Risk. The British Journal of Ophthalmology , Mar